|
Director
Mr. Chan develops commercialization and reimbursement strategies for pharmaceutical, biotechnology and medical device manufacturers, bringing over nine years of health policy and reimbursement experience. Recent experience has included the design and execution of market studies using primary and secondary data collection to inform product-positioning strategies; evaluating U.S. reimbursement risks and opportunities, and conducting a broad market assessment for a growth hormone product in development for several therapeutic indications in order to determine market potential in each indication, prioritize clinical development programs and inform the design of clinical studies. In addition, he has managed a number of pricing, message testing, awareness and key opinion leader identification research initiatives, as well as consulted with clients regarding Medicare, Medicaid and private payer reimbursement policies. Mr. Chan has also been responsible for monitoring legislation and regulations that affect the delivery of cancer care, and for conducting analyses that determined the impact on cancer patients and providers. He has worked with members of Congress, federal agencies, patient advocacy groups, health care organizations and industry to develop and advocate for health policies that ensure patients access to quality cancer care. Mr. Chan received his undergraduate degree in biology from the University of Virginia and his MBA from The George Washington University.
Contact me now...
See also...
Andrew Ferrara, President
Joseph V. Ferrara,
Executive Vice President
Anna Robbertz, Vice
President
Erica Bisguier, Executive Director
Gina Ford, Executive Director
Michael Bragin, Director
Philip Cyr, Director
Rob Wenthold, Director
|
